OPI (Opiates) Rapid Drug Test

Features:

• Results available in about 5 minutes

• 2000 ng/mL cutoff level for detecting opiates in urine

• Simple dip-and-read format for quick and easy testing

• Also available in single-panel strip formats

• High accuracy for consistent and reliable screening

• Same-day shipping on all orders

• Free shipping on bulk purchases of 100+ units

• FDA Approved and CLIA Waived

What is OPI?

OPI refers to opiates, a class of drugs derived from or chemically related to compounds found in the opium poppy. Commonly screened opiates include morphine and codeine. Opiates can affect the central nervous system and may produce pain-relieving, sedating, and euphoric effects.

Prescription and non-prescription exposure to opiates can result in side effects such as drowsiness, impaired coordination, nausea, and respiratory depression. Opioid-related medications and substances can also carry a risk of misuse, dependence, and overdose.

12 Panel Now offers a high-quality OPI Rapid Drug Test Dip Card designed to detect opiates in urine samples at a 2000 ng/mL cutoff level, providing fast and reliable screening for professional testing environments.

OPI Drug Test Dip Card

Fast and Reliable Opiate Detection

The OPI Dip Card is designed to identify the presence of opiates in urine samples quickly and conveniently. Its simple dip-and-read format provides an efficient way to screen for opiate exposure in professional testing environments.

With a 2000 ng/mL cutoff level, this test provides a defined screening threshold for detecting opiates in urine samples and supports consistent preliminary testing.

Why It’s Important to Test

OPI testing can be useful in workplace, clinical, treatment, monitoring, and other professional testing programs where screening for opiate exposure is appropriate.

A test with a 2000 ng/mL cutoff level provides a standardized screening threshold for detecting opiates, helping testing programs obtain consistent preliminary results.

Drug screening can support safety and monitoring programs by identifying presumptive positive results that may require additional evaluation or confirmatory testing.

What You Should Know

Opiates such as morphine and codeine can affect the central nervous system and may cause pain relief, sedation, and other effects. Opioid exposure can also be associated with impaired coordination, respiratory depression, tolerance, and dependence.

An OPI screening test is designed to detect its specified target analytes or related compounds at or above the established cutoff. A positive screening result does not, by itself, establish the specific drug taken, timing, dosage, or circumstances of use.

Results should be interpreted according to the manufacturer’s instructions and applicable testing procedures. When appropriate, presumptive positive screening results should be confirmed using an appropriate laboratory method.

For these reasons, consistent testing with a defined 2000 ng/mL cutoff can be useful for screening, monitoring, and professional testing programs.

How to Use an OPI Dip Test

1. Remove the dip card from the sealed foil pouch and take off the cap.

2. Dip the exposed test strips into a urine sample for 10–15 seconds.

3. Allow the sample to migrate up the test strips.

4. Replace the cap and place the device on a clean, flat, non-absorbent surface.

5. Read the results after 5 minutes.

Clinical Use Product

This product is FDA Approved and CLIA Waived, making it suitable for use in clinical settings, physician offices, and workplace testing programs.

CLIA Waived status indicates that the test is simple to perform when used according to the manufacturer’s instructions. These tests are commonly used in point-of-care environments for rapid screening purposes.

This device is not designated for forensic use.

Why Choose Our OPI Test?

The OPI Drug Test Dip Card provides a fast, convenient, and easy-to-use solution for screening urine samples for opiates. Its streamlined design allows for efficient testing with results available in minutes.

The 2000 ng/mL cutoff provides a defined screening threshold for consistent OPI testing in professional and clinical environments.

The 12 Panel Now Advantage

12 Panel Now is committed to supplying high-quality drug and wellness testing products at competitive prices. Our product range includes both single-panel and multi-panel devices, manufactured under strict quality standards.

Customers benefit from dependable performance, bulk pricing options, same-day shipping, and responsive customer support.